Exposure Therapy: Enhancing fear extinction
Memories of aversive or negative events are central to the survival of animals. However, fear learning and memory can become a challenge in people with certain conditions, such as specific phobias, anxiety or PTSD. Such individuals often avoid certain activities or situations, or start to transfer their fear to new stimuli. This avoidance strategy may help reduce fear in the short term, but but it can increase distress in the long term.
One method to alleviate fear is exposure therapy, in which individuals are subjected to objects or situations they are afraid of in a safe environment, without experiencing harm (Craske et al., 2018). For example, for someone with a fear of dogs, exposure-based therapy might include looking at pictures of dogs. This will initially produce a fear response that can include physiological changes, such as perspiration and elevated heart rate, and psychological changes, such as an increase in subjective fear. After several exposures to these stimuli, both physiological and psychological indices of fear will decline.
While this ‘extinction’ method is highly effective in minimizing fear in the short term, fear reduced through this method is highly susceptible to relapse. Even patients and subjects showing no signs of fear at the end of therapy are likely to experience a rebound after a certain amount of time or when they are re-exposed to the distressing stimulus (Bouton et al., 2021; Vervliet et al., 2013).
Decades of research suggests that this re-appearance of symptoms happens because extinction creates a new inhibitory memory that competes with – rather than updates – the original fear memory. Recent learning theories suggest that learned events are assigned a ‘prediction error’: if the prediction error is large (i.e., the new experience differs greatly from the past one) a new association will be formed. But if the prediction error is small (and the new experience is similar to the past one), the existing memory will be updated or overwritten with new information. Since fear- and anxiety-based disorders are on the rise, identifying intervention and treatment strategies to mitigate fear in a long term, relapse-resistant manner is therefore of upmost importance (Jacob et al., 2021; Siegel et al., 2022).
Now, in eLife, Nathan Holmes and colleagues – including Nicholas Kennedy as first author – report evidence that supports this recent learning theory (Kennedy et al., 2024). Kennedy et al. used a classical conditioning protocol in which they conditioned rats to fear a tone (conditional stimulus) by pairing its presentation with a brief electric shock applied to the foot (unconditional stimulus). Following this training, rats responded with freezing to the tone alone.
The researchers then used two different procedures to reduce the rats’ fear. The first group received a ‘standard’ extinction procedure during which the rats were exposed to several presentations of the sound only. The second group received a new ‘gradual’ extinction procedure, during which the tone was paired with a gradually weakened shock voltage: from 0.8 to 0.4, 0.2, and 0.1 mA. While both the traditional and gradual extinction lessened the fear response, the gradual procedure was able to also reduce relapse.
Relapse was tested at different time points following extinction treatment. When animals were re-exposed to the tone two weeks after the extinction procedures, the traditional group showed an increase in fear (e.g., more freezing) while the gradual extinction group showed less fear. The gradual extinction group was also less likely to relapse even when the animals received a brief foot shock without sound (known as ‘reinstatement’) after the extinction treatment. However, both groups were similarly susceptible to relapse if there was a change in environmental conditions from conditioning to extinction, for example, changing the physical chamber or waiting a long time between conditioning and extinction (Figure 1). Thus, the efficacy of gradual extinction relies on similar contextual parameters during conditioning and extinction to optimally minimize relapse.
Collectively, these results add to a growing literature that suggests manipulating the intensity of an unconditional stimulus (such as an electric shock) following training can have a substantial advantage over standard extinction treatments in reducing fear long-term. Kennedy et al. provide a clear explanation for these results that supports recent learning theories: too much variation between the original training shock and what occurs during extinction (as experienced in the standard group) is more likely to create a new inhibitory memory. On the other hand, a smaller change (as is experienced in the gradual extinction group) is more likely to weaken aspects of the original memory and is thus able to reduce fear long term.
These results present a promising first step in increasing the efficacy of extinction-based treatments. A next step will be to test the neural mechanisms that contribute to this effect to determine if and how this process differs from standard extinction practices, and if it could in fact be more similar to other processes relevant for updating memory, such as reconsolidation.
References
-
State-of-the-art and future directions for extinction as a translational model for fear and anxietyPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences 373:20170025.https://doi.org/10.1098/rstb.2017.0025
-
Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in GermanyJournal of Psychiatric Research 143:528–533.https://doi.org/10.1016/j.jpsychires.2020.11.029
-
Nothing to fear but fear itself: a mechanistic test of unconscious exposureBiological Psychiatry 91:294–302.https://doi.org/10.1016/j.biopsych.2021.08.022
-
Fear extinction and relapse: state of the artAnnual Review of Clinical Psychology 9:215–248.https://doi.org/10.1146/annurev-clinpsy-050212-185542
Article and author information
Author details
Publication history
Copyright
© 2024, Trask and Ferrara
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 808
- views
-
- 81
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
- Neuroscience
Hypothalamic kisspeptin (Kiss1) neurons are vital for pubertal development and reproduction. Arcuate nucleus Kiss1 (Kiss1ARH) neurons are responsible for the pulsatile release of gonadotropin-releasing hormone (GnRH). In females, the behavior of Kiss1ARH neurons, expressing Kiss1, neurokinin B (NKB), and dynorphin (Dyn), varies throughout the ovarian cycle. Studies indicate that 17β-estradiol (E2) reduces peptide expression but increases Slc17a6 (Vglut2) mRNA and glutamate neurotransmission in these neurons, suggesting a shift from peptidergic to glutamatergic signaling. To investigate this shift, we combined transcriptomics, electrophysiology, and mathematical modeling. Our results demonstrate that E2 treatment upregulates the mRNA expression of voltage-activated calcium channels, elevating the whole-cell calcium current that contributes to high-frequency burst firing. Additionally, E2 treatment decreased the mRNA levels of canonical transient receptor potential (TPRC) 5 and G protein-coupled K+ (GIRK) channels. When Trpc5 channels in Kiss1ARH neurons were deleted using CRISPR/SaCas9, the slow excitatory postsynaptic potential was eliminated. Our data enabled us to formulate a biophysically realistic mathematical model of Kiss1ARH neurons, suggesting that E2 modifies ionic conductances in these neurons, enabling the transition from high-frequency synchronous firing through NKB-driven activation of TRPC5 channels to a short bursting mode facilitating glutamate release. In a low E2 milieu, synchronous firing of Kiss1ARH neurons drives pulsatile release of GnRH, while the transition to burst firing with high, preovulatory levels of E2 would facilitate the GnRH surge through its glutamatergic synaptic connection to preoptic Kiss1 neurons.
-
- Medicine
- Neuroscience
Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3-induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive DRG neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying neuronal mechanisms of pain inhibition induced by FLO and HC-HA/PTX3.